Startups

Associate Scientist / Scientist I, Computational Test Development

Precede Biosciences · Boston, MA · Hybrid

← All jobs
About Precede Biosciences

Backed by 5AM Ventures.

About the role

Execute data analyses supporting assay characterization across multiple epigenomic and NGS-based diagnostic tests — from raw data processing through performance metric generation Design and implement quality assessment frameworks to evaluate assay and pipeline performance, including QC metric definition, threshold setting, and failure mode identification

What they're looking for

  • MSc in computational biology, bioinformatics, biostatistics, or a closely related quantitative field with 3–4 years of industry or post-graduate research experience in a data-intensive biological or biomedical setting, Ph.D. preferred
  • Strong proficiency in R and Python for data analysis, visualization, and reproducible reporting — you write, own, and document your own code
  • Experience with cloud computing environments (AWS) for running scalable analyses
  • Demonstrated ability to execute analytical plans with precision and efficiency, managing multiple tasks without a drop in quality or documentation standards
  • Familiarity with NGS data types and standard processing pipelines — alignment, QC, coverage analysis, or equivalent
  • Clear and organized communicator — written documentation, results presentations, and cross-functional interactions alike
More about this role

The Opportunity

We are seeking a motivated and detail-oriented Associate Scientist / Scientist I to join our Computational Test Development team at Precede Biosciences. Reporting to our Senior Director, Computational Test Development, this role is focused on the execution and analysis that underpins our diagnostic assay characterization and validation programs.

This is a hands-on computational role. You will run analyses, build and maintain quality assessment frameworks, execute in silico simulations, and generate the data-driven outputs that feed directly into our regulatory submissions. If you are energized by rigorous data analysis, take pride in clean and reproducible work, and are excited to contribute to diagnostics that could change how cancer is detected and treated, we want to hear from you.

About Us

We are pioneering an advanced, minimally invasive, comprehensive epigenomics platform with the potential to profoundly impact the research and development of new medicines and the use of approved medicines in clinical practice across a number of conditions, including cancer. More information on our company and platform can be found on our company website and in our seminal...

Read the full posting on Precede Biosciences's site ↗

Computational Biology and Bioinformatics

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.